Divincell
  • Accueil
  • Technologie
  • Nos programmes
  • L’équipe
  • Actualité
  • Contact
  • EN
Sélectionner une page

Aanastra Inc and DivIncell present preclinical data on its in vivo anti-CD19 CART program at the AACR Annual

Aanastra Inc and DivIncell present preclinical data on its in vivo anti-CD19 CART program at the AACR Annual Meeting, Chicago, April 25-30, 2025 

← Aanastra Inc and Divincell SAS present a “Peptide-based nanoparticle platform for extrahepatic Aanastra Inc and Divincell present preclinical data on its p53 tumor suppressor rescue and its in vivo anti-CD19 →

25 avril 2025

Last posts
Nos dernières parutions
  • Aanastra Inc and Divincell SAS will be presenting  “the PEP-NP
  • Aanastra Inc and Divincell  to highlight its technology in Multiple Presentations
  • Aanastra Inc and Divincell Announce Presentations of Preclinical Data
  • Aanastra Inc/DIVINCELL present their Peptide-based Nanoparticle platform
  • Aanastra Inc/DIVINCELL present Peptide-based Nanoparticle platform
Suivez-nous
Follow us
  • Suivre
LIENS

L’équipe
Technologie
Programmes
Actu

INFORMATIONS

Confidentialité
Mentions Légales
Plan de site

DIVINCELL

442 rue Georges BESSE
30000 Nîmes
0650740869
divincell@divincell.com

Copyright © 2026 - DIVINCELL - Conception AMBE Design
  • Suivre
LINKs

Team
Technology
Programs
News

INFO

Privacy Policy
Legal Notice
Sitemap

DIVINCELL

442 rue Georges BESSE
30000 Nîmes
0650740869
divincell@divincell.com

Copyright © 2026 - DIVINCELL - Conception AMBE Design
  • Suivre